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Synthesis of Functionalized Cyciopropanes by MIRC Reactions 
of Aziridinyl-methylenemalonates. 
Ikuo Funaki, Roel P.L. Bell, Lambertus Thijs and Binne Zwanenburg* 
Department ofOrganic Chemistry, NSR Center for Molecular Structure, Design and Synthesis, University of 
Nijmegen, Toernooiveld, 6525 ED Nijmegen, The Netherlands 
Abstract: The synthesis of cyclopropane d rivatives via a MIRC reaction of azidirinyl-methylene- 
malonates is described. In this way it is possible to introduce a hydrogen, a phenylthio, a tributylstannyl 
and an olefinic function at the cyclopropane ring, that further contains an alkylamino substituent, Addition 
of CuCN catalyzed Grignard reagents gave the most promising results. The diastereoselectivity was 
dependent onthe aziridine nitrogen substituent and the bulkiness ofthe reagent. 
Copyright © 1996 Elsevier Science Ltd 
INTRODUCTION 
The intramolecular ring opening of aziridinecarboxamides by a nucleophilic enter at the ~/-atom in the 
carboxamide part was the subject of a previous paper from our laboratorieJ The required nucleophilic site was 
generated by removal of a suitable acidic proton leading in general to a highly substituted lactarn. To further 
explore intramolecular ring-opening reactions of functionalized aziridines, the inducing nucleophilic site was 
positioned at the 13-atom relative to the aziridine-ring. In principle, such a nucleophile can be obtained by a 
deprotonation process. However, an alternative method was chosen, which was inspired by the work of 
Kasatkin et al. 1 These authors reported recently the synthesis of cyclopropane dicarboxylates u ing Michael- 
reaction Initiated Ring Closure (MIRC) reactions 2,3 of diethyl (2, 3-epoxybutylidene)malonate (Sch me 1). 
CH3, ~ O CO2Et RM 
""C-~ CO2 Et Cul ~ 0  ~ ~r -JCO2Et 
r~ OEt / R 
R= Alkyl, Ph; M= Li, MgX 38 - 85% 
Scheme 1 
Application of the MIRC reaction in an analogous manner to activated aziridines could be of interest and 
could illustrate the potential of aziridinyl-methylenemalonates for the synthesis of functionalized 
cyclopropanes. 4 However, aziridinyl-methylenemalonates can react with a nucleophile by two distinctly 
different pathways, as is shown in scheme 2. The desired pathway a involves conjugate addition of the 
nucleophile followed by opening of the aziridine ring. The alternative pathway b is a direct nucleophilic 
opening of the three-membered ring. In the proposed scheme 2, the choice of the N-activating roup may be of 
great importance for the success of the reaction. Reactions of 13-aziridinyl-ct,13-enoates with organo-copper 
reagents have been investigated whereby predominantly anti  -SN2' products are produced. 5 In the system which 
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is proposed for the present investigations, uch an SN2' reaction seems highly improbable because of the 
strongly activated methylenemalonates nd is therefore not further taken into account. 2b The formation of four- 
membered ring systems instead of three-membered was not observed. 
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(Nucleophilic attack at the C-2 aziridine carbon is omitted in this scheme.) 
Scheme 2
RESULTS AND DISCUSSION 
Preparation ofdiethyl aziridinyl-methylenemalonate derivatives. The required aziridines 3 were prepared 
as shown in Scheme 3. For this study racemic aziridines 6 were used because the prime interest was the 
diastereoselectivity during the Michael additions. Direct reduction of 1-tosyl-3-hexyl-aziridine-2-carboxylic 
acid ethyl ester la to the aldehyde 2a 7 followed by condensation with diethyl malonate afforded diethyl 
aziridinyl-methylenemalonate 3a. 8 1-Mesyl-3-hexyl-aziridine derivative 3b, 1-tosyl-3-methyl-aziridine 3e, ]-(2- 
mesityl-sulfonyl)-3-methyl-aziridine 3d a d 1-(2-mesitylsulfonyl)-3-hexyl-aziridine 3e were prepared similarly. 
In the condensation using TiC14-pyridine, chlorinated side-products were observed as a result of aziridine ring- 
opening reactions. The degree of chlorination differed among substrates 3, and depended on the 2-substituents 
and sulfonyl groups (from 0% for 3e to 41% for 3a). 
R 
I 
R, N b H 1.2eqDIBAH 
H""~"'COzEt CH2Cl2;-78°C 
la; R = -SO2-Tol (Ts), R' = Hex 
lb; R = -SO2-CH 3 (Ms), R' = Hex 
le; R=Ts, R'=Me 
ld; R = -SO2-2,4,6-(CH3)3C6H2, R' = Me 
le; R = -SO2-2,4,6-(CH3)306H2, R '= Hex 
R R 
I I 
R' .~_~H diethyl malonate R',IV_.~H CO2Et 
-. TiCI4, pyridine ~' H ~," ~,//---,L.CO2E t 
H" %CHO THF, rt 
2a (84%) 3a (52%) 
2b (86%) 3b (62%) 
2c (41%) 3c (65%) 
2d (91%) 3d (95%) 
2e (59%) 3e (97%) 
Scheme 3
Reactions of 1-tosyl-aziridine derivative 3a. Several products can result from these reactions of 3 (vide 
supra). Compounds 4 and 7 (Scheme 4) are the result of a conjugate reaction. Subsequent cyclization of the 
initial products 4 and 7 leads to cyclopropanes 5 and 8, respectively. The compounds 6 and 9 are the result of a 
direct SN2-type opening of the aziridine ring (see pathway b in Scheme 2). The diastereomer ratio's of the 
cyclopropanes 5 and 8 were determined by 400 MHz tH NMR spectroscopy. 
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It was felt that organocuprate reagents hould be suitable for selective MIRC reactions because of their 
high conjugate addition potential 9. When higher order organocuprates were used (Table l), dimethyl 
Table 1. Reactions of aziridinyl-methylenemalonate 3  with various nucleophilic reagents 
Entry Reaction Conditions R Product (yield in %) 
4 5 
1 Me2Cu(CN)Li 2, Et20, -30 °C, 3h Me 4a (0) 5a (59) a 
2 Bu2Cu(CN)Li2, Et20, -30 °C, 3h Bu 4b (24) 5b (trace) 
3 Bu2Cu(CN)Li2 BF3, Et20 ,-30 °C ,3h Bu 4b (54) 5b/6b (27) b 
4 BuCu(CN)MgBrBF 3, Et20, -30 °C, 3h Bu 4b (29) 5b (53) c 
5 BuCu(CN)MgBrBF 3, THF, -30 °C, 3h Bu 4b (65) 5b (trace) 
6 BuMgBr, 10 mol% CuCN, Et20, Bu 4b (0) 5b (91) d 
-78 °C - rt, 2h 
(Vinyl)MgBr, 10 mol% CuCN, Et20, Vinyl 4c (31) e 
-78 °C - rt, 4h 
Bu2C=CH-CuMgBr2 SMe2, 4d (0) 
Et20, -30 - 0 °C, 4h 
(Bu3Sn)BuCu(CN)Li 2, Et20, -30 °C, 3h Bu3S n 4e (16) 
PhSNa, THF, -50 °C, 3h PhS 4f (64) 
K-Selectride, THF, 0 °C, lh H 4g (0) 
7 5c (44) f 
8 Bu2C=CH- 5d (51)f 
9 5e (30) g 
10 5f(0) 
11 6g (79) 
a 1:1 Mixture of cis/trans diastereomers, b Total yield of the mixture is shown. 6b:6b 
= 45:55. CisJtrans ratio of 5b, ca. 65:35. c The minor diastereomer could not be 
detected by 1H NMR spectroscopy, dCis/trans ratio 85:15. ecis/trans ratio not 
determined, fcis/trans ratio 90:10. gcis/trans ratio 75:25. 
cyanocuprate gave cyclopropane 5a (entry 1), but, the dibutyl derivative gave a very poor result (entry 2). Three 
equivalents of reagent were used in these reactions to obtain acceptable yields (entries 1-5). Boron trifluoride 
etherate has been reported as an effective co-additive for organocuprates, I° and Bu2Cu(CN)Li2BF3 did indeed 
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improve the conjugate addition (entry 3). As an alternative butyl-donor, BuCu(CN)MgBrBF3OEt2 was used 
and it showed high reactivity and isomeric selectivity (entry 4). The cyclopropane derivative 5b was obtained 
uncontaminated with the S~2 reaction products 6b. It is of interest hat when tetrahydrofuran was used as 
solvent, only the conjugate addition product 4b was obtained containing only traces of cyclization product 5b 
(entry 5). 
It was found necessary to carry out the reaction at higher temperatures in order to improve the chemical 
yield further. But, use of excess of reagents (3 equiv; entries 1-5) does not permit higher eaction temperatures 
since organocuprate r agents are known to open the aziridine ring at a temperature higher than -20 °C.JX 
Therefore a stoichiometric amount of Grignard reagent was added in the CuCN catalyzed reaction (entry 6). 
This resulted in an excellent yield with high degree of stereoselectivity (85:15). Although the vinyl group could 
also be introduced, a considerable amount of uncyclized product 4c was observed even after a prolonged 
reaction time (4h) at room temperature ( ntry 7), Whilst the stereoselectivity of 5c was surprisingly high 
(90:10) for this small nucleophile, the diastereomer ratio of 4e could not be determined (it was likely to be low, 
considering the low diastereoselectivity observed uring the methyl introduction i  entry 1). It was assumed 
that a high stereoselectivity for the introduction of an unsaturated function might be achieved with a more 
sterically hindered group. For this purpose, alkenylcoppermagnesium dibromide ,2 was prepared in situ and 
submitted to the MIRC reaction (entry 8). Although the chemical yield was moderate, a high stereoselectivity 
was observed (90:10). 
Lipshutz et al. reported the direct formation of trialkyltin cuprates from tin hydrides.13 The alkylstannyl 
function is of value because of its potential for lithium-transmetalation with stereo-retention. 14 Tributyltin 
cuprate transferred the tributyltin group in moderate yield (entry 9) with a disappointing stereoselectivity 
(75:25). 
Sodium thiophenoxide, another nucleophilic reagent, gave conjugate addition product 4f only (entry 10), 
and K-selectride transferred hydride to ultimately give cyclopropane d rivative 5g in good yield (entry 11). is 
Reactions of  1-mesyl-aziridine derivative 3b. The reactions of the aziridine derivative 3b, which carries 
the methylsulfonyl (mesyl) group as the aziridine-activating group were examined briefly (Table 2). 
Table 2. Reactions of aziridinyl-methylenemalonate 3b with various nucleophilic reagents 
Entry Reaction Conditions a R Product (yield in %) 
7 8 
1 Me2Cu(CN)Li2, Et20 Me 7a (42) 8alga (38) b 
2 Bu2Cu(CN)Li2, Et20 Bu 7b (40) 8b (16) c 
3 Bu2Cu(CN)Li2BF 3, Et20 Bu 7b (23) 8b (23) c 
4 Bu2Cu(CN)Li 2, THF Bu 7b (43) 8b (trace) 
a -30 °C, 3h. b R = H in 9a, Cis/trans ratio of 8a ca. 55:45. Total yield of the mixture is 
shown. 8a/9a = 83:17. c The minor diastereomer was not detected by 1H NMR spectroscopy. 
The reaction trend of 3b was almost he same as that of 3a. Me2Cu(CN)Li2 showed approximately the 
same degree of stereoselectivity with 3b (ca. 55:45 ratio; Table 2, entry 1). Surprisingly, a considerable amount 
of uncyclized product 7a was observed. 16The cyclopropane 8a was obtained as an inseparable mixture with 9a 
(R=H).II~ 17 Bu2Cu(CN)Li2 reacted with an almost exclusive stereoselectivity in contrast to the reaction of 3a 
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(Table 1, entry 3, and Table 2, entry 2), and the cyclopropane 8b could be isolated. In contrast o the 
accelerative effect of BF3 on 3a, the organocuprate boron trifluoride complex did not dramatically change the 
outcome of the reaction of 3b (entry 3). Although the exclusive formation of one diastereomer 8b was 
impressive, the stereoselectivity during the reactions of 3b with the butylorganocuprate reagents i in the same 
range as that observed for 3a. The high diastereopurity of 5b was also observed (Table 1, entry 4). In 
accordance with the solvent effect of THF noted earlier (Table 1, entry 5), THF prevented cyclization (entry 4). 
The uncyclized compounds 4b, 4e, 4f, 7a and 7b were then treated with a catalytic amount of NaOEt in 
EtOH at room temperature (Scheme 5). The reactions of 4b, 7a and 7b proceeded in excellent yields affording 
diastereomerically pure cyclized products. Unexpectedly, the yield of the vinylcyclopropane 5c was relatively 
low. The cyclopropane 5e isolated was dominantly rich of a single isomer, which was recomfirmed by ~3C 
NMR spectroscopy. This isomer showed a significant N.O.E. between H-2 and H-3, establishing the 2,3-cis- 
configuration (cis/trans ratio 90:10). The cyclization reactions of 4b, 7a and 7b gave exclusively single 
isomers. These results indicate that 4b, 7a and 7b are highly rich of one type of diastereomers. Surprisingly, 
compound 4f derived from 3a and sodium thiophenoxide id not give any cyclization when treated with NaOEt 
in EtOH. 
EWG NH-EWG 
, H, , , .~ £O2E t 
Hex~N.~ ,CO2Et cat. NaOEt/EtOH 
" , ,~,CO2E t rt, overnight l= Hex- H~ ''~'~CO2Et 
R R 
4b; EWG = Ts, R = Bu 5b (95%) a 
4e; EWG = Ts, R = CH=CH 2 5c (58%) b 
4f ; EWG = Ts, R = SPh no cyclopropane 
7a; EWG = Ms, R = Me 8a (quantitative) a 
7b; EWG = Ms, R = Bu 8b (quantitative)a 
Scheme 5
a The minor trans diastereome 
was not detected by 1H NMR 
spectroscopy. 
b cis/trans ratio 90:10. 
Reactions of aziridine derivatives 3c, 3d and 3e. In order to investigate further the steric influence of 
substituents on the reaction of the aziridine rings, reactions of 3a, 3e, 3d and 3e with Grignard reagents in the 
presence of 10 tool% CuCN were examined (Table 3). When 3-methyl-l-tosyl-aziridine derivative 3c was 
treated with BuMgBr/CuCN, the cyclopropane d rivative 10 was obtained in 51% yield with a stereoselectivity 
of 85:15. Under the reaction conditions, the aziridine ring-opened compound 11 was also obtained (21% 
yield).18 
When the 1-(mesitylsulfonyl)-3-methyl-aziridine der vative 3d was subjected to the MIRC reaction with 
the MeMgI/CuCN reagent, a Me group was transferred togive product 12 in 46% yield; the diastereomer ratio 
was 40:60 (entry 4). This stereoselectivity is not substantially different from that observed for 3a (entry 1). The 
steric effect of the mesitylsulfonyl group may be reduced by sulfonamide inversion (vide infra). 
BuMgBr/CuCN similarly gave the desired cyclopropane 13 in 48% yield with high diastereoselectivity 
(diastereomeric ratio 91:9). In these reactions, no aziridine ring-opened compounds, such as 11, were 
detected) 8 The modest yields obtained from 3e and 3d are possibly due to decomposition of the aziridines 
since they were consumed totally during the course of the reactions. 
3-Hexyl-l-(mesitylsulfonyl)-aziridine 3e, which bears large substituents on both the aziridine nitrogen 
and the aziridine C-3 atom, produced a cyclopropane derivative with high stereoselectivity. It is especially 
noteworthy that the methyl substituted cyclopropane derivative 14 was obtained with an exceptionally high 
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diastereoselectivity (79:21) considering a methyl transfer had occurred. The diastereoselectivity for the 
introduction of a butyl group (entry 6) was the same as that found for compound 13. 
Table 3. Reactions of aziridinyl-methylenemalonates 3c-3e with Grignard reagents catalyzed by CuCN 
R 1 1.2 eq. R3MgX/10 tool% CuCN (X=Br, I) 
R%N Et20, -78 °C- rt, 3h 
~,,,~._~. .CO2Et 
"%~(~CO2E t NH-R 1 
H~,..~ ,C02Et 
3 H,,,,~CO2E t R ~ . + 
R 3 
5a, 10, 12-15 
NH-R~,cO2Et 
Me"~CO2Et 
Bu Bu 
11; R 1 = Ts (21% for 3c only) 
Entry Aziridine R 1 R 2 R 3 Cyclopropane Yield (%) Cis/transratio 
1 3a Ts Hex Me 5a 97 60:40 
2 3a Ts Hex Bu 5b 91 85:15 a 
3 3c Ts Me Bu 10 51 85:15 
4 3d SO2-2,4,6-(CH3)3C6H2 Me Me 12 46 40:60 
5 3d SO2-2,4,6-(CH3)3C6H2 Me Bu 13 48 91:9 
6 3e SO2-2,4,6-(CH3)3C6H2 Hex Me 14 60 79:21 
7 3e SO2-2,4,6-(CH3)3C6H2 Hex Bu 15 69 90:10 
a This is the same experiment as shown in Table 1, entry 6. 
Stereochemistry. The ]H NMR spectra of the diastereomerically pure cyclopropane d rivatives 5b, 8a, 8b 
and 15 unfortunately exhibited a complicate coupling pattern and it has not been possible so far to assign the 
configurations at the cyclopropane C-3 atom. The coupling constants (J H-2. H-3) of single-diastereomer-rich 
(90:10) cyclopropanes 5e and 5d was 9.7 Hz. Braun 19 observed coupling constants of 7.5 Hz for trans- 
vinylcyclopropane and 9.0 Hz for the corresponding cis isomer. Kasatkin et aL i observed a 5 Hz coupling for 
the trans isomers and 8 Hz for the cis isomers (cf Scheme 1). The vinylcyclopropane 5  was convincingly 
shown to have a 2,3-cis -configuration by NOE measurement, and the cyclopropane 5d was therefore assigned 
to have the 2,3-cis -configuration also. 
The chemical shift pattern of all major diastereomers of 5b-e, 8a, 8b, 10, 13, 14, and 15 are very similar, 
which suggests that they all have the same relative configuration about the C-3 atom. Assuming this is valid, 
we tentatively assigned the relative configuration at the C-3 atom of the major cyclopropane diastereomers a  
cis, because the C-3 configuration of the vinylcyclopropane 5  was determined to be cis (vide supra). It was 
anticipated that the consideration of the transition state of the conjugate addition reaction might provide a 
support for the assignment. 
When the N-substituent of the aziridine ring was altered from tosyl to the mesitylsulfonyl group, there 
was an increase of the degree of the cis/trans ratio (Table 3, compare ntries 1, 2, 3 with entries 6, 7, 5 
respectively). This effect was not observed when the tosyl group was changed for the mesyl group (Table 2); 
the degrees of the cis/trans ratio's during the reactions of the two types of N-substituents were observed to be 
essentially identical. It is very, noteworthy that the mesitylsulfonyl group provided the 79:21 cis/trans ratio 
during the reaction of the aziridine 3e and methylmagnesium iodide (Table 3, entry 6) but the mesyl group 
produced a 1:1 mixture of the methylcyclopropane derivatives (Table 2, entry 1). 
Yamamoto et aL studied the diastereoselectivity of the conjugate addition of organocuprate reagents to "/- 
alkoxy eqlS-unsaturated diester derivatives. 9 They discussed whether apowerful Michael acceptor having a high 
electron-accepting ability or a reactive copper reagent having a high electron-donating ability is prone to 
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produce a n-complex (Figure 1). When the 7-t-butyldimethylsilyloxy (TBDMS) containing Michael acceptors 
(R'=TBDMS; the TBDMS is a "non-chelating" roup), reacted with organocopper reagents, the steric bulk 
difference between R and R' determined the outcome. The electron-deficient nitrogen atom of the aziridines 
may be assumed to be comparatively non-chelating as is the oxygen atom of the tert-butyldimethylsilyloxy 
group. If this Yamamoto's approach is applied to the aziridinyl-substituted Michael acceptors described here, 
the conjugate reactions could occur through the transition state model shown in Figure 2. In this model, the 
preferred conformation arising from rotation about he single bond between the aziridinyl C-2 atom and the 
olefinic carbon is incorporated. The model is presented as a Newman projection viewed along this bond. The 
1,3-allylic strain theory 2° supports this configuration i which the hydrogen atom on the aziridine C-2 is 
positioned inside. Another elevant aspect is the relative position of the C-3 substituent and the N-arylsultbnyl 
group. It is presumed that the steric effect is more influential than the bond-orbital effect. 21 Molecular models 
show considerable differences of the steric environment around C-3 and sutfonamide group when this group 
inverts. The preponderant conformational isomer of 3 with respect o the sulfonamide group is likely to be the 
one where the C-3 alkyl group and the N-sulfonyl group are positioned on opposite sides of the aziridine ring 
and the sulfonyl group covers the upper side of the methylene double bond. The largest group on the aziridine 
of this isomer is the sulfonamide group, which is assumed to occupy the anti position in the model with C-3 on 
the outside position, as shown in Figure 2. In the alternative minor aziridine invertomer, the C-3 alkyl 
substituent and the N-sulfonyl group are positioned on the same side. Thus, the sulfonyl group does not shield 
the double bond and the aziridine C-3 substituent is now the largest group and located in an anti position. 
Nucleophilic attack at the Michael acceptor can take place from both sides of the double bond when there is no 
shielding effect. Attack from the upper side should produce the 2,3-trans -cyclopropane whereas the 2,3-cis- 
cyclopropane should result by attack at the alternative lower face. By taking into account that in the preferred 
conformation (as shown in Figure 2) the upper face is shielded by the N-sulfonyl group, the formation of the cis 
product is favored. 
anti 
R 
R~.~'CO2Et ~ ~,CO2Et  
l C02Et R'O~K'~2~H " "~C02Et 
R'O NU(~ULn 
outside 
inside 
Figure l. Yamamoto's model 
N..N~,R' 
R '~ "CO2Et ~1 ~/ -  -~ / ~  ~COzEt . .  
co2Et Nu u o-c°2E' 
R 3 (R'=ArSO2) R 
cis product 
Figure 2. A model for the preferred conformation faziridine 3
Some information about he inversion of the nitrogen atom in these aziridine derivatives was obtained 
from temperature d pendent ~H NMR measurements. At a temperature of-63 °C, the H-3 aziridine ring proton 
of 3a shows up as two signals in the ratio of 70:30. Although the exact reaction temperature at which the 
conjugate addition occurs is not clear, this NMR analysis is consistent with the experimental result. Since 30% 
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of the aziridine 3a seems to possess the conformation with the tosyl group on the side opposite to the 
unsaturated diester moiety, conjugate addition of nucleophiles can occur equally well from both sides of the 
double bond leading therefore to the 50:50 ratio. Meanwhile, the other conformer (70%) allows nucleophiles to
approach from only one side of the double bond. This results in 85:15 cis/trans ratio observed uring the 
reaction with BuMgBr. 
The transition state model shown in Figure 2 indicates that the variation of substituents at the aziridine C- 
3 position (methyl or hexyl) would probably have only a slight effect on the diastereoselectivity, because the 
steric environment around the aziridine C-3 is less crowded than that around the nitrogen of the tosylamido 
group due to the trans-configuration. Nucleophilic approach should be preferred from the bottom side leading 
to 2,3-cis-cyclopropane (r actions of3a - e). The size of this C-3 substituent may influence however the ratio of 
the aziridine invertomers; the smaller the substituent the more this ratio shifts to 1 : l, and therefore the size of 
the C-3 substituent will indirectly affect the shielding of the upper face of the Michael acceptor. The 
experiments ofthe substrates 3a and 3¢ with BuMgBr/CuCN as the reagent showed no significant difference in 
the cis/trans ratio. The reaction of MeMgI/CuCN with 3d showed a lower diastereoselectivity. Apparently, the 
sterically hindered mesitylsulfonyl group does not shield the upper side of the unsaturated diester moiety 
sufficiently to prevent attack by the small nucleophile from the upper face. This result supports the supposition 
that the conforrnational preference of this substrate is less outspoken, presumably because the small C-3 
substituent (methyl) has only little effect on the ratio of the sulfonamide invertomers (almost 1:1 ratio) and 
therefore diminishing the shielding over the Michael acceptor. In contrast substrate 3e which has a larger hexyl 
group at C-3 shows a much higher diastereoselectivity (Table 3, entry 6) in its reaction with the MeMgI/CuCN 
reagent. Clearly, the preponderant conformational isomer in Figure 2 is now much more predominant due to the 
steric repulsion between the large mesitylsulfonyl group and the C-3 (hexyl) group when compared with 3e, 
implying that in 3e the mesitylsulfonyl group exerts an effective shielding effect on the olefinic moiety which 
results in a high diastereoselectivity. When the more bulky reagent BuMgBr/CuCN is used in these MIRC 
reactions, invariably excellent diastereoselectivity wasachieved (Table 3, entries 2, 3, 5 and 7). This result is 
readily explained as the sterically demanding reagent will be more sensitive to steric constraint in the substrate, 
meaning that the least hindered pathway will be followed in the course of the approach of nucleophiles. 
In order to gain further support for the proposed transition state model, cis aziridine derivative 16 was 
subjected to the MIRC reaction (Scheme 6). 
Ts 
CO2Et 
CHs~%O2E t 
H H 
16 
NH-Ts 
NL_/T, Bu C BuMgBr/ ~ z .CO2Et CH31 O2Et 
• ,,. CH3/"°-/\. ' ' \  + H" .,,.~-"~ 10 mol% CuCN 
ether, .78 oC to ~ ''- H~f~'-~H CO2Et H;" ¢~,CO2Et 
U 17 (37%) 
EUEtOH~~. CH3 TSl lS (24%) 
NaO ~ O :  
rt, overnight xK HH%~.~._7.,,oCO2Et_ .  
Scheme 6 ~"%H Bu 19 (66%) 
This substrate molecule was conveniently prepared from threonine (see the Experimental Section). 
Aziridine 16 reacted with BuMgBr/CuCN to yield the cyclopropanedicarboxylate 18 in 24% yield. The IH 
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NMR chemical shift pattern suggested that the configuration of 18 was 2,3-trans. The uncyclized product 17 
was also obtained in a considerable amount (37%). Compound 17 was converted to compound 19 on treatment 
with NaOEt/EtOH overnight at room temperature. Cyclization under the last-mentioned conditions was 
followed by a lactamization reaction which was not observed for the trans-aziridine substrates. 
The formation of the trans-cyclopropane product 18 can be explained by adopting the same approach as 
for the trans-aziridine 3. The preferred conformation of 16 leading to the transition state is strongly governed 
by the 2,3-cis configuration f the C-3 methyl group and the olefinic moiety. This cis relationship forces the N- 
tosyl group on the side opposite to both the C-3 methyl group and the olefinic moiety. The shielding effect on 
the Michael acceptor, therefore, will not be as effective as in the substrate 3c. The configuration f the aziridine 
C-3 of 16 is opposite to that of 3e and inspection of molecular models uggests that the preferred conformation 
can be pictured as shown in Figure 3, whereby the methyl group is shielding the bottom side. As a consequence 
the nucleophilic reagent, BuMgBr/CuCN, is primarily directed toward the upper face of the Michael acceptor. 
Ts Ts NuCuLn 
~. .CO2Et N u 
N .,,,~--~, N¢'-.,C'-~H', ,,,~CO2Et 
CH31,,..~H CO2Et ~=:  ':~'~CO2E t 
H 16 l"llCH3 
H 
trans-product 
Figure 3. Newman projection of the preferred conformation f aziridine 16 
The amount of uncyclized product 17 formed during the reaction of 16 with the Grignard reagent is too 
large to be ignored. The trans-cyclopropane i  this case seems to be formed reluctantly. The explanation for 
this reluctance isnot yet known. 
Reactions with Hetero-Organocuprate Reagents. During the discussion of the results presented inTable 3 
(vide supra), it was indicated that more sterically demanding nucleophilic reagents increase the 
diastereoselectivity of the MIRC reaction. Further elaboration of this observation leads to the suggestion that 
better diastereoselectivity may be obtained when copper eagents with a large "dummy" volume are employed. 
Hetero-organocuprates po sibly provide such a "dummy" volume. The non-transferable group R' in RR'CuM 
with M being Li or MgBr can be residues derived from alcohols, thiols, amines or alkynes. The effect of non- 
transferable R' group on the MIRC reaction was investigated. Grignard reagents were used instead of organo 
lithium reagents as the source of the transferable R group because of easier availability. 
Initially, methyl transfer was implemented with hetero-organocuprates, but attempts based on a common 
procedure using preformed MeCu and R'Li did not give cyclopropanes. It is known that the extent of 
stereoselectivity of organocuprate r agents is influenced by various factors such as the structure of the 
substrate, solvent, concentration f reagents, presence of salts and the reaction temperature. 22 The sequence of 
addition was inversed with MeMgBr being added to the preformed R'Cu (Table 4). The R'Cu compounds were 
conveniently prepared by addition of an etherial solution of R'Li to an etherial suspension of CuI. The use of 
two equivalents of MeMgBr is essential for achieving the desired conjugate addition. The use of only one 
equivalent ofthe Grignard reagent resulted in recovery of unchanged 3a (entry 2). 
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The results shown in Table 4 indicate that indeed the diastereoselectivity of the MIRC reaction improves 
as the steric bulk of R' increased. The combination of diisopropylamine and diethyl ether (entry 7) resulted in a 
high reaction yield and a high diastereoselectivity, but a lower chemical yield with higher diastereoselectivity 
was observed using dimethyl sulfide as solvent (entry 6). The chemical yield and diastereoselectivity was most 
satisfactory using (-)-terpinen-4-ol (entry 5). 
In the set-up of the experiments collected in Table 3, the mesitylsulfonyl group was selected as the second 
aziridine activating function with the objective to improve the diastereofacial selectivity during the conjugate 
addition. It was therefore surprising that reactions of 1-(mesitylsulfonyl)-aziridine d rivative 3e with hetero- 
organocuprates involving the use of diisopropylamine and terpinenol resulted in diastereomer ratio's ranging 
from 67:33 to 80:20. The diastereoselectivity even varied under the same reaction conditions. Although no 
clear answer is yet available for this observation, the following explanation is proposed. 
In the preferred configuration (Figure 2) leading to the transition state where the N-arylsulfonyl group 
shields the olefinic moiety, the bulky mesitylsulfonyl group of 3e provokes more serious repulsion with the 
olefinic moiety. The mesitylsulfonyl group, therefore, cannot sustain the anti position and rotates slightly 
outside to ease the repulsion (Figure 4). This rotation at the same time means the move of the C-3 hexyl group 
of the aziridine toward the anti position. But when the hexyl group occupies the anti position, there will be 
much less space for the nucleophilic reagents to form a n-complex from the lower face of the olefinic moiety in 
Figure 4. Because of this rotation, the voluminous hetero-organocuprates do not experience an energetic 
Table 4. Reactions of 3a with hetero-organocuprate eagents 
Ts NH-Ts 
I H- , , .~CO2Et  
Hex N CO2E t 2.1eq. MeMgBr/1.2eq. R'Cu " 
~.__~..,ps/~j~_ \ ~" Rex . , -V \  
-78 °C - rt, 3.5h . H "? Y'I, CO2Et 
3a CO2 Et ~a Me 
Entry R'H Solvent Yield (%) Cis/trans ratio 
1 t-BuOH Et20 80 81:19 
2 t-BuOH Et20 0 a 
3 Cyclohexanol Et20 95 79:21 
4 DL-Menthol Et20 69 76:24 
5 (-)-Terpinen-4-ol Et20 78 87:13 
6 Diisopropylamine Me2S 64 87:13 
7 Diisopropylamine Et20 95 82:18 
8 Dicyclohexylamine Me2S 64 84:16 
9 Hexamethyldisilazane Me2S 45 87:13 
a 1.1 eq. MeMgBr was used. 64% of 3a was recovered. 
advantage during the attack from the lower side of the olefinic moiety. Meanwhile, since one extra equivalent 
of MeMgBr is present (and required), certain amount of uncomplexed Grignard reagent may well exist in 
equilibrium with the organocuprate complex. These free species may be able to approach the upper face and the 
lower face of the Michael acceptor with comparable ease. 
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N "rrSO2"C6H2(CH3)3 
/~~CO2Et 
H,,,. ~.~H! '~CO2Et 
He~x~Nul~uLn 
Figure 4. A model for the preferred contbrmation f aziridine 3e 
CONCLUSIONS 
The occurrence of Michael-reaction Initiated Ring Closure (MIRC) reactions of aziridinyl- 
methylenemalonates 3 and 16 has been established. A variety of substituents could be introduced onto the 
resulting cyclopropane dicarboxylic ester derivatives with a highly diastereoselective formation of the cis- 
isomer (cis'trans ratio's ranged from 50:50 to 91:9). Conjugate addition to the methylenemalonate moiety was 
much more favorable than direct aziridine ring opening due to the presence of the activating malonate system. 
Grignard reactions catalyzed by CuCN appeared to be the most promising because clean reactions with a high 
degree of diastereoselectivity were achieved. Even the small methyl group was introduced with a relatively high 
diastereoselectivity (cis.trans ratio of 87:13). 
It is of interest to note that he preference for the formation of the cis-cyclopropane derivatives i  opposite 
to that observed by Kasatkin ~6 during the MIRC reaction of the epoxide analogue. This difference can be 
attributed to the influence of the arylsulfonyl group at the aziridine nitrogen atom on the preferred conformation 
of the substrate 3 in the transition state. In this conformation, one face of the Michael acceptor is effectively 
shielded by the N-arylsulfonyl group implying aselective approach of the nucleophilic reagent to the other face 
of the double bond moiety. For the substrate 16 which has a cis-substituted aziridine ring, the formation of 
trans-cyclopropane derivatives i predominant. This stereochemical course could be explained similarly by 
invoking the preferred conformation leading to the transition state. 
The results obtained suggest that steric interactions between the nucleophilic reagent and the substituents 
of the three-membered heterocyclic ring are of importance ingoverning the stereochemical outcome. Moreover, 
the stoichiometry and the sequence of addition of hetero-organocuprates play a significant role. 
EXPERIMENTAL SECTION 
Proton and 13C magnetic resonance spectra were measured on a Bruker AC-100 or a Bruker AM-400 
spectrometer. Chemical shift values are reported as 8-values relative to tetramethylsilane as an internal 
standard. Mass spectra were obtained with a double focussing VG 7070E spectrometer. IR spectra were 
recorded on a Perkin-Elmer 298 infrared spectrophotometer. Melting points were measured with a Reichert 
Thermopan microscope and are uncorrected. Recrystallizations were carried out using hexane-EtOAc unless 
stated otherwise. GLC was conducted with a Hewlett-Packard HP 5890 gas chromatograph, using a capillary 
column (25m) of HP-1, and nitrogen at 2 ml/min (0.5 atm) as the carrier gas. Commercial n-BuLi solution in 
hexane (ca. 1.6 M) was purchased from Merck. MeMgBr (3.0 M in Et20) was purchased from Aldrich 
Chemical Co. and was diluted with Et20 to make a 1.0 M solution. (Vinyl)MgBr (1.0 M in tetrahydrofuran) 
was also purchased from Aldrich Chemical Co. tert-Butyl alcohol, hexane and dimethyl sulfide were distilled 
from calcium hydride, and menthol was recrystallized from pet.-ether (60-80), and other alcohols, cyclohexanol 
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and terpineol were simply distilled before use. All amines for hetero-organocuprates, i. . diisopropylamine, 
dicyclohexylamine and hexamethyldisilazane were distilled over calcium hydride under Ar prior to use. Diethyl 
ether was pre-dried over calcium chloride, then distilled from calcium hydride and again from sodium hydride. 
Tetrahydrofuran was freshly distilled from lithium aluminumhydride. All other solvents were obtained 
commercially and used unpurified. Thin-layer chromatography (TLC) was performed on silica gel F-254 plates 
(thickness 0.25 ram). Spots were visualized with a UV hand lamp, K2Cr207 solution in diI.H2SO4 or C12- 
TDM. 23 Column chromatography was performed using silica 60H (for flash chromatography, Merck, art. nr, 
7736) or silica 60 (Merck, art. nr. 7734). 
trans-2-Formyl-3-hexyl-aziridine erivatives: The synthesis of trans-2-formyl-3-hexyl-l-(toluene-4- 
sulfonyl)-aziridine 2a is representative. A hexane solution of diisobutylaluminumhydride (I .0 M, 2.7 mL, 2.7 
retool) was added to a cooled (-78 °C) solution of ethyl trans-3-hexyl-l-(toluene-4-sulfonyl)-aziridine-2- 
carboxylate la (0.80 g, 2.3 mmol) in dichloromethane (11 mL) under At. On completion of the addition, the 
mixture was stirred for a further one hour when a solution of sodium fluoride (0.94 g) in water (0.72 mL) was 
added. The reaction mixture was allowed to warm slowly to room temperature and the white solid thus 
obtained was collected. The filtrate was concentrated in vacuo and column chromatography (hexane-EtOAc 
(4:1)) of the residual oil afforded trans-2-formyl-3-hexyl-l-(toluene-4-sulfonyl)-aziridine 2a (0.60 g, 1.9 mmol) 
in 84% yield. 
trans-2-Formyl-3-hexyi-l-(toluene-4-suifonyl)-aziridine (2a). Oil; IR (CC14) 2920, 1718, 1450, 1340 
cmZ; IH NMR (CDCI3) 8 0.78-0.98 (m, 3H, CH3CH2), 1.08-1.85 (m, 10H, CH3(CH2)5), 2.46 (s, 3H, C6H4CH3), 
3.08 (dd, J = 3,3, 6.7 Hz, IH, NCHCHO), 3.25-3.45 (m, IH, HexCHN), 7.38 (d, J = 9.4 Hz, 2H, 3, 5-C6H4), 
7,86 (d, J = 9.4 Hz, 2H, 2, 6-C6H4), 9.44 (d, J = 6.6 Hz, 1H, CHO); HRMS (M+I)+; Calcd for Cj6H24NO3S: 
310.14769; Found: 310.14759 ainu. 
trans-2-Formyl-3-hexyl-l-methylsulfonyi-aziridine (2b). 86% yield; 2b was obtained as an oil in a 
similar manner; JH NMR (CDC13) 8 0.78-1.01 (m, 3H, CH3CH2), 1.01-1.92 (m, 10H, CH3(CH2)5), 3.03-3.20 
(re+s, 4H, SO2CH3, CH2CHN), 3.22-3.44 (m, IH, NCHCHO), 9.33 (d, J = 6.7 Hz, IH, CHO); HRMS (M+I)+; 
Calcd for CIoH20NO3S: 234.11639; Found: 234.11641 amu. 
Ethyl 3-methyl-l-(2,4,6-trimethylbenzenesulfonyl)-aziridin-2-carboxylate. A stirred cooled (0 °C) 
solution of ethyl 3-methyl-aziridin-2-carboxylate (0.70g, 5.4 mmol), Et3N (1.5 mL, 11 retool) and a small 
catalytic amount of DMAP in CH2C12 (50 mL) maintained under Ar was treated with mesitylenesulfonyl 
chloride (1.5 g, 6.5 mmol). The mixture was stirred at 0 °C for 30 min and then at room temperature for 2 days, 
whereon it was treated with saturated aqueous NH4CI (50 mL) and extracted with CH2C12 (3x30 mL). The 
combined organic extracts were washed with brine, dried (MgSO4) and concentrated in vacuo. Column 
chromatography (hexane-EtOAc (7:1)) of the residue gave the N-(2,4,6-trimethylbenzenesulfonyl)-aziridine 
derivative as an oil (0.89 g, 53% yield). IR (CCI4) 2980, 1750, 1600, 1510, 1330, 1240 cmq; IH NMR (CDCl3) 
6 1.21 (t, J : 7.2 Hz, 3H, OCH2CH3), 1.71 (d, J = 5.9 Hz, 3H, CH3CHN), 2.30 (s, 3H, 4-CH3-C6H2), 2.70 (s, 
6H, 2, 6-(CH3)2C6H2), 3.02-3.23 (m, 1H, CH3CHN), 3.32 (d, J = 3.9 Hz, 1H, NCHCO2Et), 4.13 (q, J = 7.1 Hz, 
2H, OCH2CH3), 6.94 (s, 2H, 3, 5-C~t/2); MS (El): m/e (relative intensity (%)) 311 (M, 32), 266 (3.0), 238 (7.5), 
174 (31), 128 (54), 119 (100), 100 (100). 
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trans.2-Formyl-3-methyl-l-(2,4,6-trimethylbenzenesulfonyl)-aziridine (2d). 91% yield; 2d was 
obtained as an oil in a similar manner starting from ethyl 3-methyl-l-(2,4,6-trimethylbenzenesulfonyl)-aziridin- 
2-carboxylate; IR (CC14)2940, 1720, 1600, 1450, 1400, 1330, 1165 cm~; IH NMR (CDC13)8 1.51 (d, J = 5.7 
Hz, 3H, CH3CHN), 2.32 (s, 3H, 4-CH3C6H2), 2.68 (s, 6H, 2, 6-(CH3)2C6H2), 3.12 (dd, J = 3.8, 6.7 Hz, 1H, 
NCHCHO), 3.32-3.54 (m, IH, CH3CHN), 6.98 (s, 2H, 3, 5-C6H2), 9.31 (d, J = 6.7 Hz, 1H, CHO); MS (EI): 
m/e (relative intensity (%)) 267 (M, 15), 174 (9.7), 119 (100), 84 (45). 
Aziridinyl-methylenemalonate d rivatives: The following synthesis of diethyl [3-hexyl-l-(toluene-4- 
sulfonyl)-aziridin-2-ylmethylene]-malonate 3a is representative. Dry THF (15 mL) was placed in a 50-mL flask 
and kept under Ar at 0 °C; TiCIa (0.33 mL, 3.0 mmol) was added with a syringe to give a yellow suspension. 
Diethyl malonate (0.22 mL, 1.5 mmol) and then 2-formyl-3-hexyl-l-(toluene-4-sulfonyl)-aziridine (0.45 g, 1.5 
mmol) each dissolved in dry THF (5 mL) were added and successively, followed by pyridine (0.48 mL, 6.0 
mmol) to give a deep red-brown solution. The mixture was stirred at room temperature for 3 days, treated with 
saturated NH4C1 aqueous olution (25 mL) and extracted with ether (3x 25 mL). The combined organic layers 
were washed with brine, dried (MgSO4) and concentrated in vacuo. Column chromatography (hexane-EtOAc 
(7:1)) of the residue gave 3a (0.35 g, 7.8 mmol) as an oil (52%). 
2-[3-Hexyl-l-(toluene-4-sulfonyl)-aziridin-2-ylmethylenel-maionic cid diethyl ester (3a). IR (CCI4) 
2920, 1720, 1330, 1250, 1160 cm-I; IH NMR (CDC13) 8 0.72-1.0 (m, 3H, CH3CH2CH2), 1.0-1.54 (m, 14H, 
CH3(CH2h, 2xOCH2CH3), 1.54-1.88 (m, 2H, CH2CHN), 2.44 (s, 3H, C6H4CH3), 2.90-3.12 (m, 1H, CH2CHN), 
3.54 (dd, J = 4.0, 10 Hz, IH, NCHCH=C), 4.25+4.31 (2xq, J = 7.1 Hz, 4H, 2xOCH2CH3), 6.98 (d, J = 10 Hz, 
IH, CH=C), 7.30 (d, J = 9.4 Hz, 2H, 3, 5-C6H4), 7.82 (d, J = 9.4 Hz, 2H, 2, 6-C6H4); HRMS (M+I)÷; Calcd for 
C23H34NO6S:452.21069; Found: 452.21060 amu. 
2-(3-Hexyl-l-methylsulfonyl-aziridin-2-ylmethylene)-malonic acid diethyi ester (3b). 3b was 
obtained similarly in 62% yield as an oil; IR (CC14) 2920, 1730, 1465, 1330, 1150 cml; 1H NMR (CDC%) 8 
0.80-1.05 (m, 3H,CH3CH2CH2), 1.15-1.95 (m, 16H, CH3(CH2)5, 2xOCH2CH3), 2.88-3.1 (m, IH, HexCHN), 
3.09 (s, 3H, SO2CH3), 3.49 (dd, J = 4.5, 10 Hz, 1H, NCHCH=C), 4.26 (q, J = 7.1 Hz, 2H, OCH2CH3), 4.34 (q, 
J = 7.3 Hz, 2H, OCH2CH3), 6.77 (d, J = 10 Hz, 1H, CH=C); HRMS (M+I)+; Calcd for C17H30NO6S: 
376.17938; Found: 376.17939 amu. 
2-[3-Methyl-l-(toluene-4-sulfonyl)-aziridin-2-ylmethylene]-malonic cid diethyl ester (3c). Methyl 
analogue 3c was prepared as above (cf. 3a) from ethyl 3-methyl-aziridin-2-carboxylate vi  he N-tosyl-aziridine 
(92% yield), reduction (41% yield) and condensation with diethyl malonate (65% yield). The product was an 
oil; IH NMR (CDCI3) 8 1.20-1.50 (m, 6H, 2xOCH2CH3), 1.58 (d, J -- 6.0 Hz, 3H, CH3CHN), 2.44 (s, 3H, 
C6HaCH3), 2.90-3.14 (m, 1H, CH3C[/N), 3.58 (dd, J = 4.5, 10 Hz, 1H, CHCHN), 4.23+4.33 (2xq, J = 7.1 Hz, 
4H, 2xOCH2CH3), 6.78 (d, J = 9.6 Hz, 1H, CH=C), 7.31 (d, J := 8.2 Hz, 2H, 3, 5-C6H4), 7.81 (d, J = 8.2 Hz, 
2H, 2, 6-C6H4). 
2-[3-Methyl-l-(2,4,6-trimethylbenzenesulfonyi)-aziridin-2-ylmethylene]-malonic acid diethyl ester 
(3d). 3-Methyl-l-(mesitylsulfonyl)-aziridine 3d was prepared in the same manner as 3a from 2d by 
condensation with diethyl malonate (95% yield), oil; IR (CC14) 2990, 1720, 1600, 1440, 1370, 1330, 1160 cml; 
IH NMR 8 1.28+1.33 (2xt, J = 7.1 Hz, 6H, 2x OCH2CH3), 1.57 (d, J = 5.8 Hz, 3H, CH3CHN), 2.30 (s, 3H, 4- 
CH3Ph), 2.67 (s, 6H, 2,6-(CH3)2Ph), 2.95-3.16 (m, 1H, CH3CHN), 3.58 (dd, J = 3.9, 9.7 Hz, 1H, NCHCH=C), 
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4.22-4.31 (2q, J = 7.1 Hz, 4H, 2x OCH2CH3), 6.78 (d, J = 9.7 Hz, 1H, CH=C), 6.95 (s, 2H, 3,5-Ph); HRMS 
(M)+; Calcd for C20H27NO6S: 409.1559; Found: 409.1558. 
2-[3-Hexyl-l-(2,4,6-trimethylbenzenesulfonyl)-aziridin-2-ylmethylene]-malonic acid diethyl ester 
(3e). 3-Hexyl-l-(mesitylenesulfonyl)-aziridine 3e was prepared in the manner of 3d from ethyl 3-hexyl- 
aziridin-2-carboxylate via the N-mesityl-aziridine (83% yield), reduction (59% yield) and condensation with 
diethyl malonate (97% yield) as an oil; IR (CC14) 2930, 1730, 1600, 1465, 1380, 1330, 1245, 1160 cm~; IH 
NMR (CDCI3) 6 0.85-0.97 (m, 3H, CH3CHaCH2), 1.15-1.50 (m, 14H, 2x OCHaCH3, CH3(CH2)4CH2), 1.60- 
1.85 (m, 2H, CH2CHN), 2.30 (s, 3H, 4-CH3C6H2), 2.68 (s, 6H, 2, 6-(CH3)aC6H2), 2.95-3.12 (m, 1H, HexCHN), 
3.54 (dd, J = 3.8, 10 Hz, IH, NCHCH=C), 4.28 (dq, J = 6.4, 7.1 Hz, 4H, 2x OCH2CH3), 6.95 (s, 2H, 3, 5- 
C6H2), 7.01 (d, J = 10 Hz, 1H, CH=C), ; HRMS (M)+; Calcd for C25H37NO6S: 479.2342; Found: 479.2337 
amu. 
Reaction with Higher-Order Alkyicopper Reagents. A stirred, cooled (-78 °C) solution of 3 equiv of 
the copper eagents in ether or THF (10 mL), was treated with a solution of 3a or 3b (0.80 retool) in ether (or 
THF; 5 mL). The mixture was allowed to warm to -30 °C, and stirring was continued at this temperature for 3h, 
when it was poured into a 3:1 mixture of saturated NH4CI aqueous olution and 25% ammonia solution (100 
mL). The usual workup procedure followed by column chromatography (hexane-EtOAc), afforded the 
products. 
The alkylcopper reagents were prepared as follows. Me2Cu(CN)Li2: An ether solution of MeLi (1.6M, 
3.0 mL, 4.8 mmol) was added slowly to a precooled (-78 °C) suspension of CuCN (0.22 g, 2.4 retool) in ether 
(or THF; 10 mL). The mixture was allowed to warm to 0 °C, and then after 10 rain, was cooled to -78 °C. 
Bu2Cu(CN)Li2: A procedure similar to that above, except for the use of BuLi (a 1.6M hexane solution) instead 
of MeLi. The preparation was carried out at -50 °C instead of 0 °C. Bu2Cu(CN)Li2"BF3:BF3 Et20 (0.65 mL, 
2.4 mmol) was added to Bu2Cu(CN)Li2 (prepared as described above) at -78 °C, and the mixture was stirred for 
5 rain. 
Reaction with Butylmagnesiocuprate'BF3 Reagents. BuMgBr (1.6M, 1.3 mL, 2.0 retool) in ether (or 
THF) was added by syringe to a stirred, cooled (-78 °C) slurry of CuCN (0.18 g, 2.0 retool) in dry ether (or 
THF; 10 mL), and the mixture was allowed to warm to 0 °C. BF3 Et20 (0.54 mL, 2.0 mmol) was added to the 
above mixture at -78 °C, which was then stirred for 5 min. A solution of diethyl aziridinyl-methylenemalonate 
3a (0.30 g, 0.67 mmol) in dry ether (or THF; 5 mL) was then added dropwise to the above reagent and the 
reaction mixture was then allowed to -10 °C (or -30 °C in the case of THF solution). Stirring was continued for 
2h (or 3h in the case of THF solution) at the respective t mperatures. The reaction mixture was poured into a 
3:1 mixture of saturated NH4CI aqueous olution and 25% ammonia solution (100 mL), processed as usual and 
subjected to column chromatography (hexane-EtOAc (7: I)) to give the products. 
Reaction with Grignard Reagents Catalyzed by CuCN. A stirred, cooled (-78 °C) mixture of diethyl 
aziridinyl-methylenemalonate 3 (0.67 retool) and CuCN (0.006 g, 0.067 retool) in the required solvents (15 
mL) was treated with a Grignard reagent (0.73 retool), and after 15 min, the mixture was allowed to warm to 
room temperature over 3h. Saturated aqueous NH4C1 solution (50 mL) was added, and the usual workup 
procedure followed by column chromatography ( exane-EtOAc) gave the products described. 
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Reaction with Alkenylcupratemagnesium bromide'dimethylsulfide r agent. A reported method i~- 
was used as follows: The dimethyl sulfide complex of cuprous bromide (0.14 g, 0.67 mmol) was placed in a 
50-mL flask maintained under argon. Dimethyl sulfide (0.67 mL) and ether (0.84 mL) were then added 
separately, and the resulting solution was cooled to -45 °C. The stirred mixture was treated with an etherial 
solution of butylmagnesium bromide (1.0 M, 0.74 mL, 0.74 retool), and after 1.5h, with 1-hexyne (0.084 mL, 
0.74 mmol). The mixture was allowed to warm to -23 °C, and was stirred at this temperature for 2.25h. The 
resulting dark green solution was cooled to -50 °C, and treated with a solution in ether (3 mL) of diethyl 
aziridinyl-methylenemalonate 3a (0.30 g, 0.67 mmol). The mixture was allowed to warm to -30 °C, stirred at 
this temperature for 2h, and then at 0 °C for 2h. The mixture was treated with saturated aqueous NH4CI 
solution and 25% aqueous ammonia (3:1, 25 mL), processed as usual, and column chromatography (hexane- 
EtOAc (10:l)) of the crude material gave the product (0.20 g). 
Reaction with Tributyltin Cuprate. The reported method was used as follows: 13 n-BuLi (I.6M in 
hexane, 0.94 mL, 1.5 mmol) was added to a stirred, cooled (-78 °C) slurry of CuCN (0.067 g, 0.75 mmol) in 
ether (10 mL). The mixture was allowed to warm slowly to -50 °C, recooled to -78 °C, whereon -Bu3SnH 
(0.40 mL, 1.5 mmol) was added by syringe. Stirring was continued for 15 min, when diethyl aziridinyl- 
methylenemalonate 3a (0.30 g, 0.67 mmol) dissolved in ether (5 mL) was added. This mixture was allowed to 
warm to -30 °C over lh, stirred at this temperature for 3h and then treated with a 3:1 mixture of saturated 
aqueous NHaCI and 25% aqueous ammonia (25 mL). The usual processing followed by column 
chromatography ( exane-EtOAc (10:1 to 7:1)) gave 4e (0.08 g, 16%) and 5e (0.15 g, 30%). 
Reaction with Sodium Thiophenoxide. A solution ofthiophenol (0.073 mL, 0.74 mmol) in THF (2 mL) 
was added to a stirred, cooled (0 °C) suspension of sodium hydride (0.018 g, 0.74 mmol) in THF (10 mL). The 
mixture was set aside for 30 rain, cooled to -78 °C and treated with a solution of diethyl aziridinyl- 
methylenemalonate 3a (0.30 g, 0.67 mmol) in THF (5 mL). After l0 rain, the mixture was allowed to warm to - 
50 °C when stirring was continued for 2.5h prior to the addition of saturated aqueous NH4CI solution (25 mL). 
The reaction mixture was extracted with ether (3x 20 mL), the combined organic extracts washed with brine, 
dried (MgSO4), and concentrated in vacuo.  Column chromatography (hexane-EtOAc (5:1)) of the residue, gave 
4f (0.24 g, 64%). 
Reaction with K-Selectride. A solution of diethyl aziridinyl-methylenemalonate 3a (0.33 g, 0.73 mmol) 
in dry THF (7 mL) was added to a stirred, cooled (-78 °C) solution of K-Selectride (1.0M, 0.80 mL, 0.80 
mmol) in THF. The reaction mixture was stirred for 15 min at -78 °C, allowed to warm to 0 °C over 1.5h, and 
after a further lh at this temperature, was treated successively with a 10% NaOH aqueous olution (0.3 mL) 
and 35% H202 (3 mL), and set aside to attain room temperature, whereon it was poured into water. The mixture 
was extracted with ether (3x 10 mL), and the combined organic extracts washed successively with saturated 
aqueous NaHCO3 solution, brine, dried (MgSO4), filtered, and concentrated in vacuo.  Column chromatography 
(hexane-EtOAc (3:1)) of the residue afforded cyclopropane 5g (0.26 g, 79%) as an oil. 
Syntheses of 5 from 4 and 8 from 7. Synthesis of 5b from 4b is representative. A stirred solution of 
aziridine 4b (0.19 g, 0.37 mmol) in EtOH (6 mL) maintained under argon, was treated with a few drops of a 
solution (1.3 M) of sodium ethoxide, set aside overnight at room temperature and then concentrated in vacuo.  
Column chromatography ( exane-EtOAc (7:1)) of the residue yielded cyclopropane 5b (0.18 g, 95%) as an oil 
The following were obtained in a similar manner: 
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3-Methyl-2-[l-(toluene-4-suifonylamino)-heptyi]-cyclopropane-l,l-dicarboxylic acid diethyl ester 
(5a). Oil; IR (CC14) 3260, 2925, 1790, 1465, 1300, 1165 cm'l; IH NMR (CDCI3) 6 0.81-0.86 (m, 3H, 
CH3CH2CH2), 1.00-1.44 (m, 18H, CH3(CH2)4CHH, CHCH3, 2xOCH2CH3), 1.45-1.84 (m, 3H, CH3CHCH, 
CH3(CH2)aCHH), 2.39+2.42 ( xs, 3H, C6H4CH3), 2.95-3.12 (m, 0.5H, CHN), 3.57-3.65 (m, 0.5H, CHN), 4.08- 
4.24 (m, 4H, 2xOCH2CH3), 4.90 (d, 3 -- 8.0 Hz, 0.5H, NH), 4.96 (d, J = 8.4 Hz, 0.5H, NH), 7.24-7.32 (m, 2H, 
3, 5-C6H4), 7.72+7.84 (2xd, J = 8.0 Hz, 2H, 2, 6-C6H4); J3C NMR (CDC13) 5 9.0, 12.8, 14.0, 14.1, 21.4, 22.4, 
24.3, 24.7, 25.0, 28.9, 29.1, 31.5, 35.3, 35.6, 35.8, 37.0, 38.5, 40.1, 50.4, 52.7, 61.1, 61.4, 61.5, 61.6, 126.8, 
127.1, 129.4, 129.5, 136.4, 139.1, 143.0, 143.1, 166.7, 167.8, 168.2, 170.3; HRMS (M+I)÷; Calcd for 
C24H38NO68: 468.24199; Found: 468.24207 amu. 
2-{1-[3-Hexyl-l-(toluene-4-sulfonyl)-aziridin-2-yl]-pentyl}-malonic acid diethyl ester (4b). Oil; IR 
(CC14) 2920, 1730, 1460, 1330, 1160 cm'l; IH NMR (CDCI3) 8 0.74-1.04 (m, 6H, 2xCH3CH2CH2), 1.04-1.7 
(m, 21H, CH3(CH2)4, BuCH, 2xOCH2CH3, CH3(CH2)3), 1.7-2.1 (m, 2H, CH2CH2CHN), 2.43 (s, 3H, 
C6H4CH3), 2.5-2.75 (m, 1H, HexCHN), 2.95 (dd, J = 5, 10 Hz, IH, NCHCHBu), 3.28 (d, J = 3.9 Hz, 1H, 
CH(CO2Et)2), 4.12 (q, J = 7.0 Hz, 2H, OCH2CH3), 4.20 (q, J = 7.1 Hz, 2H, OCH2CH3), 7.30 (d, J = 8.3 Hz, 2H, 
3, 5-C6H4), 7.85 (d, 3 = 8.3 Hz, 2H, 2, 6-C6H4); HRMS (M)÷; Calcd for C27H43NO6S: 509.2811; Found: 
509.2811 ainu. 
3-Butyl-2-[1-(toluene-4-sulfonylamino)-heptyi]-cyclopropane-l,l-dicarboxylic acid diethyl ester. 
The mixture of (5b) and (6b); oil; 1H NMR (CDC13) 6 0.81-0.93 (m, 6H, 2xCH3CH2CH2), 1.0-1.40 (m, 20H, 
CHffCH2)2CH2CH, CH3(CH2)5, 2xOCH2CH3), 1.44-1.80 (m, 4H, CH2CH2CHCH), 2.41 (s, 3H, C6HnCH3), 
2.50-2.58 (m, 0.55H, CHN), 3.21-3.27 (m, 0.5H, CHN), 2.95-3.06 (m, < 0.10H, CHN), 3.65-3.74 (m, 0.30H, 
CHN), 4.11-4.24 (m, 3H, OCH2CH3, OCHHCH3), 4.29 (q, J = 7.2 Hz, 1H, OCHHCH3), 4.54-4.59 (m, 0.35H, 
NH), 5.00 (d, J = 8.0 Hz, 0.5H, NH), 6.48 (d, J = I 1 Hz, 0.5H, CH=C), 7.24-7.31 (m, 2H, 3, 5-C6H4), 7.70-7.78 
(m, 2H, 2, 6-C6H4). 
The single isomer (5b); oil; IR (CC14) 3260, 2920, 1720, 1455, 1320, 1230 cmI; IH NMR (CDCI3) 6 
0.70-0.95 (m, 6H, 2xCH3CH2CH2), 0.95-1.40 (m, 20H, CH3(CH2)4, CH3(CH2)3, 2xOCH2CH3), 1.50-1.60 (m, 
2H, CH2CH2CHN), 1.60-1.75 (m, 2H, CHCHBu), 2.41 (s, 3H, C6H4CH3), 3.50-3.85 (m, 1H, CHN), 4.16+4.18 
(2xq, J = 7.1 Hz, 4H, 2xOCH2CH3), 4.56 (d, J = 7.9 Hz, IH, NH), 7.27 (d, 3 = 8.3 Hz, 2H, 3, 5-C6H4), 7.75 (d, 
J = 8.3 Hz, 2H, 2, 6-C6H4); |3C NMR (CDC13) ~ 14.0, 21.4, 22.4, 23.2, 23.9, 29.2, 29.7, 31.0, 31.3, 31.6, 35.2, 
35,4, 36.7, 50.4, 61.1, 61.6, 126.9, 129.5, 138.9, 143.1, 167.0, 170.3; HRMS (M)+; Calcd for 
C27H43NO6S:509.2811; Found: 509.2811 amu. 
2-{1-[3-Hexyi-l-(toluene-4-suifonyl)-aziridin-2-yl]-2-propenyl}-malonic acid d ethyl ester (4c). Oil; 
IR (CC14) 2920, 1730, 1455, 1330, 1160 cml; 1H NMR (CDCI3) 8 0.76-1.10 (m, 3H, CH3CH2CH2), 1.10-2.20 
(m, 16H, CH3(CH2)5, 2xOCH2CH3), 2.44 (s, 3H, C6H4CH3), 2.50-2.75 (m, 2H, HexCHN, CHCH=CH2), 3.09 
(dd, J = 5, 8 Hz, 1H, NCHCHCH=CH2), 3,31+3.41 (2xd, J = 6 Hz, IH, CH(CO2Et)2), 4.00-4.35 (m, 4H, 
2xOCH2CH3), 4.92-5.26 (m, 2H, CH=CH2), 5.38-6.10 (m, 1H, CH=CH2), 7.31 (d, J = 9 Hz, 2H, 3, 5-C6H4), 
7.80-7.95 (m, 2H, 2, 6-C6H4); HRMS (M+I)+; Calcd for C25H38NO65: 480.24199; Found: 480.24187 ainu. 
2-[1-(Toluene-4-sulfonylamino)-heptyl]-3-vinyi-cyclopropane-l,l-dicarboxylic acid diethyl ester 
(5c). Oil; IR (CC14) 3260, 2920, 1720, 1460, 1320, 1160 cml; IH NMR (CDC13) 6 0.83-0.94 (m, 3H, 
CH3CH2CH2), 1. I0-1.30 (m, 14H, CH3(CH2)4CH2, x OCH2CH3), 1.50-1.60 (m, 2H, CH(CH2)4CH2), 1,88 (dd, 
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J = 9.7, 9.7 Hz, 0.90H, H-3), 2.42+2.44 (2s, 3H, C6H4CH3), 2.35 (dd, J = 9.7, 9.7 Hz, 0.90H, H-2), 2.60-2.78 
(m, 0.20H, H-2, H-3), 3.60-3.70 (m, 0.90H, CHNH), 4.18 (q, J = 7.1 Hz, 4H, 2x OCH2CH3), 3.02-3.12 (m, 
0.10H, CHNH), 4.71 (d, J = 6.9 Hz, 1H, NH), 5.01 (dd, J = 1.7, 17 Hz, 1H, CH=CH2), 5.20 (dd, J = 1.7, 17 Hz, 
IH, CH=CH2), 5.29-5.38 (m, 1H, CH=CH2), 7.27 (d, J = 8.2 Hz, 1.8H, 3, 5-C6H4), 7.33 (d, J = 8.2 Hz, 0.2H,3, 
5-C6H4), 7.73 (d, J = 8.2 Hz, 1.8H, 2, 6-C6H4), 7.93 (d, J = 8.2 Hz, 0.2H, 2, 6-C6H4); t3C NMR (CDCI3) 8 14.0, 
21.4, 22.5, 24.1, 29.1, 31.6, 33.8, 35.1, 35.6, 50.7, 61.4, 61.9, 119.9, 127.1, 129.4, 129.5, 138.5, 143.1, 166.1, 
169.2; HRMS (M+I)+; Calcd for C25H38NO6S: 480.24199; Found: 480.24211 amu. 
2-(2-Butyi-hex- 1-enyl)-3-[1-(toluene-4-sulfonylamino)-heptyl]-cyclopropane-l,l-dicarboxylic acid 
diethyi ester (5d). Oil; IR (CC14) 3260, 2960, 1720, 1450, 1320, 1160 cm~; IH NMR (CDC13) 6 0.82-0.92 (m, 
9H, 3xCH3CH2CH2), 1.12-1.33 (m, 22H, CH3(C[-12)4 , 2xCH3CCH2)2, 2xOCH2CH3), 1.50-1.75 (m, 2H, 
CH2CHN), 1.78 (dd, J = 9.7, 10 Hz, 1H, H-2), 1.82-2.05 (m, 4H, CH=C(CH2)2), 2.41 (s, 3H, C6HaCH3), 2.50 
(dd, J = 9.5, 9.7 Hz, IH, H-3), 3.75-3.84 (m, 0.90H, CHNH), 4.06-4.22 (m, 4H, 2x OCH2CH3), 3.00-3.10 (m, 
0.10H, CHNH), 4.49 (d, J = 6.8 Hz, 0.12H, NH), 4.65 (d, J = 6.8 Hz, 0.88H, NH), 4.84 (d, J = 9.5 Hz, 1H, 
CH=C), 7.24 (d, J = 8.4 Hz, 2H, 3, 5-C6H4), 7.73 (d, J = 8.4 Hz, 1.8H, 2, 6-C6H4), 7.93 (d, J = 8.4 Hz, 0.2H, 2, 
6-C6H4); HRMS (M+I)+; Calcd for C33H53NO6S: 592.3672; Found: 592.3670 ainu. 
2•{•3-Hexy•-•-(t••uene-4-su•f•ny•)-aziridin-2-y•]-(tri-buty•stanny•)-methy•}-ma••nic ac d diethyl 
ester (4e). Oil; IR (CC|4) 2920, 1730, 1460, 1330, 1180 cml; tH NMR (CDC13) 8 0.72-1.05 (m, 12H, 
4xCH3CH2CH2), 1.05-2.10 (m, 34H, CH3(CH2)5, 3xCH3(CH2)3, 2xOCH2CH3), 2.12-2.35 (m, 1H, CHSn), 2.43 
(s, 3H, C6H4CH3), 2.51-2.74 (m, 1H, HexCHN), 2.94 (dd, J = 6, 9 Hz, 1H, NCHCHSn), 3.29 (d, J = 6 Hz, 1H, 
CH(CO2Et)2), 4.12+4.19 (2xq, J = 7 Hz, 4H, 2xOCH2CH3), 7.30 (d, J = 8 Hz, 2H, 3, 5-C6H4), 7.85 (d, J = 8 
Hz, 2H, 2, 6-C6H4). 
2-tri-Buty•stanny•-3-[•-(t••uene-4-su•f•ny•amin•)•hepty•]-cyc••pr•pane-•••-dicarb•xy•ic acid 
diethyl ester (5e). Oil; IR (CC14) 3270, 2920, 1720, 1455, 1320, 1210 cml; 1H NMR (CDCI3) 8 0.81-0.93 (m, 
12H, 4xCH3CH2CH2), 1.00-1.40 (m, 29H, 2xOCH2CH3, CH3(CH2)4, 3xSn(CH2)3CH3), 1.40-1.65 (m, 4H, 
3xSnCH2CH2), 1.65-1.75 (m, 2H, CH2CHN, CHCHSn), 1.80-1.90 (m, IH, CHSn), 2.41+2.42 (2xs, 3H, 
C6H4CH3), 2.88-3.08 (m, 0.25H, CHN), 3.59-3.64 (m, 0.75H, CHN), 4.10-4.35 (m, 4H, 2xOCH2CH3), 4.73 (d, 
J = 7.6 Hz, IH, NH), 7.25-7.29 (m, 2H, 3, 5-C6H4), 7.74-7.79 (m, 2H, 2, 6-C6H4). 
2-{[3-Hexyl-l-(toluene-4-sulfonyl)-aziridin-2-yl]-phenylthio-methyl}-malonic acid diethyl ester (40. 
Oil; IR (CC14) 2920, 1730, 1440, 1330, 1160cm'~; IH NMR (CDC13) 8 0.75-1.04 (m, 3H, CH3CH2CH2), 1.04- 
1.5 (m, 14H, CH3(CH2)4, 2xOCHzCH3), 1.5-1.9 (m, 2H, CH2CHN), 2.34+2.43 (2xs, 3H, C6HaCH3), 1.75-3.04 
(m, 1H, CHSPh), 3.1-3.4 (m, IH, HexCHN), 3.42-3.62 (m, 2H, NCHCHS, CH(CO2Et)2), 4.05-4.32 (m, 4H, 
2xOCH2CH3), 7.16-7.50 (m, 7H, SPh, 3, 5-C6H4CH3), 7.73-7.90 (m, 2H, 2, 6-C6H4CH3); HRMS (M)+;Calcd 
for C29H39NO6S2: 561.2219; Found: 561.2220 amu. 
2-[1-(Toluene-4-sulfonylamino)-heptyl]-cyclopropane-l,l-dicarboxylic acid diethyl ester (5g). mp: 
69-71 °C; IR (CC14) 3260, 2920, 1715, 1440, 1320 cm~; ~H NMR (CDC13) 8 0.84 (t, J = 7.2 Hz, 3H, 
CH3CH2CH2), 1.04-1.32 (m, 16H, CH3(CH2)5, 2xOCH2CH3), 1.32-1.45 (m, 1H, NCHCHCH2), 1.45-1.55 (m, 
1H, NCHCHCH2), 1.86 (dt, J = 8.5, 8.5 Hz, 1H, NCHCHCHz), 2.42 (s, 3H, C6H4CH3), 2.95-3.02 (m, IH, 
CHN), 4.09-4.25 (m, 4H, 2xOCH2CH3), 4.66 (d, J = 8.4 Hz, 1H, NH), 7.29 (d, J = 8.0 Hz, 2H, 3, 5-C6H4), 7.76 
(d, J = 8.0 Hz, 2H, 2, 6-C6H4); t3C NMR (CDC13) 8 14.0, 19.9, 21.5, 22.4, 24.9, 28.9, 29.7, 31.6, 32.7, 34.3, 
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35.7, 53.7, 61.6, 127.1,129.6, 138.4, 143.3, 167.7, 169.4; HRMS (M+I)+; Calcd for C23H36NO6S: 454.22634; 
Found: 454.22612 amu; Anal. Calcd for C23H35NO6S: C, 60.90;H, 7.78; N, 3.09; S, 7.07. Found: C, 60.78; H, 
7.86; N, 2.99; S, 6.84. 
2-[l-(3-Hexyl-l-methylsulfonyl-aziridin-2-yl)-ethyl]-malonic acid diethyl acid (7a), Oil; IR (CC14) 
2920, 1725, 1444, 1366, 1318 cm'l; IH NMR 6 0.78-1.02 (m, 3H, CH3CH2CH2), 1.09-1.6 (m, 18H, 
CH3(CH2)qCHH, CH3CH, 2xOCH2CH3), 1.6-1.9 (m, 1H, CH3(CH2)nCHH), 1.9-2.35 (m, IH, CH3CH), 2.48- 
2.65 (m, 1H, HexCHN), 2.78 (dd, J = 4.4, 8.4 Hz, 1H, NCHCHCH3), 3.14 (s, 3H, SO2CH3), 3.59 (d, J = 4.8 
Hz, 1H, CH(CO2Et)2), 4.22+4.25 (2xq, J =7.2 Hz, 4H, 2xOCH2CH3); HRMS (M+I)*; Calcd for CIsH34NO6S: 
392.21068; Found: 392.21063 amu. 
2-[1-(Methylsulfonylamino)-heptyl]-3-methyl-cyclopropane-l,l-dicarboxylic acid diethyl ester (8a). 
The mixture with the aziridine-protonated compound (9a); oil; IR (CCIq) 3260, 2920, 1730, 1440, 1340, 1150 
cml; IH NMR (CDCI3) 6 0.85-0.90 (m, 3H), 1.11-1.6 (m, 18H), 1.71-1.96 (m, 2H), 2.16 (dd, J = 7.2, 7.2 Hz, 
0.5H), 2.5-2.6 (m, 0.14H), 2.90+2.98 (2s, 0.5H), 2.98+3.02 (2s, 2.5H), 3.12-3.16 (m, 0.5H), 3.40-3.49 (m, 
0.07H), 3.50-3.51 (m, 0.07H), 3.66-3.80 (m, 0.5H), 4.14-4.31 (m, 4H), 4.69 (d, J = 8.0 Hz, 0.3H), 4.80 (d, J = 
8.4 Hz, 0.5H), 5.02+5.08 (2xd, J = 8 Hz, 0.07H), 6.9 (d, J = 8 Hz, 0.04H), 7.04 (dd, J = 8, 8 Hz, 0.04H). 
The pure cyclopropane (8a); oil; IR (CCI4) 3300, 2920, 1723, 1455, 1320, 1150 cm~; IH NMR (CDCI3) ~5 
0.79-1.03 (m, 3H, CH3CH2CH2), 1.19-1.61 (m, 19H, CH3CH, CH3(CH2)5, 2xOCH2CH3), 1.61-1.93 (m, 2H, 
CH3CHCH), 3.00 (s, 3H, SO2CH3), 3.6-3.88 (m, 1H, CHN), 4.06-4.33 (m, 4H, 2xOCH2CH3), 4.47 (d, J = 8.0 
Hz, 1H, NH). 
2-[1-(3-Hexyl-l-methylsulfonyl-aziridin-2-yl)-pentyl]-malonic acid diethyl ester (7b). Oil; IR (CC14) 
2920, 1735, 1600, 1465, 1325, 1150 cm't; IH NMR (CDC13)5 0.80-1.08 (m, 6H, 2xCH3CH2CH2), 1.10-1.84 
(m, 22H, CH3(CH2)4CHI-I, BuCH, CH3(CH2)3, 2xOCH2CH3), 1.84-2.24 (m, 1H, CHHCHN), 2.5-2.7 (rn, 1H, 
CHN), 2.84 (dd, J = 4.0, 8.2 Hz, 1H, NCHCHBu), 3.14 (s, 3H, SO2CH3), 3.64 (d, J = 4.1 Hz, IH, 
CH(CO2Et)2), 4.22+4.24 (2xq, J --- 7.1 Hz, 4H, 2xOCH2CH3); HRMS (M+I)+; Calcd for C21Ha0NO6S: 
434.25764; Found: 434.25772 ainu. 
3-Butyl-2-[1-(methylsuifonylamino)-heptyi]-cyclopropane-l,l-dicarboxylic acid diethyl ester (Sb). 
Oil; IR (CC14) 3270, 2920, 1720, 1460, 1325, 1220 cml; 1H NMR (CDCI3) 8 0.75-0.93 (m, 6H, 
2xCH3CH2CH2), 1.21-1.64 (m, 20H, CH3(CH2)4, CH3(CH2)3, 2xOCH2CH3), 1.64-1.90 (m, 4H, CH2CHN, 
CHCHBu), 2.99 (s, 3H, SO2CH3), 3.6-3.95 (m, 1H, CHN), 4.18+4.20 (2xq, J = 7.1 Hz, 4H, 2xOCH2CH3), 4.53 
(d, J = 8.1 Hz, 1H, NH); HRMS (M+I)+; Calcd for C21H40NO6S: 434.25764; Found: 434.25772 amu. 
3-Butyl-2-[1-(toluene-4-suifonylamino)-ethyi]-cyciopropane-l,l-dicarboxylic acid diethyl ester (10). 
Oil; Rf = 0.21 (hexane:EtOAc =3:1), column chromatography was conducted using hexane-EtOAc (7:1) as 
eluent; IH NMR (CDC13) 8 0.83-0.91 (m, 3H,CH3(CH2)3), 1.09-1.39 (rn, 14H, CH3(CH2)2CHI-I, CH3CH, 
2xOCH2CH3), 1.57-1.80 (m, 3H, CH3(CH2)2CHHCH, BuCHCH), 2.41 (s, 3H, C6H4CH3), 3.00-3.08 (m, 0.15H, 
CHNH), 3.50-3.58 (m, 0.85H, CHNH), 4.09-4.23 (m, 4H, 2xOCH2CH3), 4.79 (d, J = 7.8 Hz, 0.85H, NH), 4.92 
(d, J = 7.8 Hz, 0.15H, NH), 7.29 (d, J = 8.4 Hz, 2H, 3, 5-C6H4), 7.76 (d, J = 8.4 Hz, 2H, 2, 6-C6H4). MS (CI): 
m/e (relative intensity (%)) 440 (M+I) + (1.0), 394 (19.8), 284 (28.7), 269 (41.3), 241 (20.4), 195 (14.6), 183 
(10.7), 155 (19.9). 
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3-Methy•-2•[•-(2•4•6-trimethy•benzenesu•f•ny•amin•)-ethy•]-cyc••pr•pane••••-dicarb•xy•ic acid 
diethyl ester (12). Purification by flash column chromatography using hexane-EtOAc (5:1) as eluent gave 12 
(0.13 g, 46%) as an oil; IR (CCI4) 3300, 2980, 1720, 1445, 1370, 1325, 1210 cm'l; IH NMR (CDCI3) 8 0.78 (d, 
J = 6.3 Hz, 1.8H, 3-CH3), 0.96 (d, J = 6.7 Hz, 1.2H, 3-CH3), 1.13 (d, J = 6.7 Hz, 1.8H, CHsCHNH), 1.18-1.29 
(m, 7.2H, CH3CHNH, 2x OCH2CH3), 1.39-1.46 (m, 0.6H, H-3), 1.61-1.68 (m, 1H, H-2, H-3), 1.78-1.81 (m, 
0.4H, H-2), 2.29+2.30 (2s, 3H, 4-CH3C6H2), 2.64+2.66+2.69 (3s, 6H, 2, 6-(CH3)2C6H2), 2.98-3.04 (m, 0.6H, 
CHNH), 3.48-3.52 (m, 0.4H, CHNH), 4.04-4.22 (m, 4H, 2x OCH2CHs), 4.78 (d, J = 8.3 Hz, 0.4H, NH), 4.97 
(d, J = 8.6 Hz, 0.6H, NH), 6.94+6.97 (2s, 2H, 3, 5-C6H2). HRMS (M)+; Calcd for C21H31NO6S: 425.1872; 
Found: 425.1875 amu. 
3-Buty•-2-[•-(2•4•6-trimethy•benzenesu•f•ny•amin•)-ethy•]-cyc••pr•pane-•••-dicarb•xy•ic acid 
diethyl ester (13). Purification by flash column chromatography using hexane-EtOAc (7:1) as eluent gave 13 
(0.15 g, 48%) as an oil; IR (CCI4) 3300, 2960, 1720, 1450, 1370, 1320, 1250, 1215 cml; IH NMR (CDC13) 8 
0.84 (t, J = 7.2 Hz, 3H, CH3CH2CH2), 1.09-1.35 (m, 15H, 2x OCH2CH3, CH3(CH2)3CH, CHsCHNH), 1.57- 
1.62 (m, 1H, H-3), 1.68-1.73 (m, 1H, H-2), 2.28+2.30 (2s, 3H, 4-CH3C6H2), 2.64+2.65 (2s, 6H, 2, 6- 
(CH3)2C6H2), 2.98-3.01 (m, 0.09H, CHNH), 3.55-3.62 (m, 0.91H, CHNH), 4.10-4.23(m, 4H, 2x OCH2CH3), 
4.52 (d, J = 8.3 Hz, 0.glH, NH), 4.67 (br s, 0.09H, NH), 6.94+6.96 (2s, 2H, 3, 5-C6H2). HRMS (M)÷; Calcd for 
C24H37NO6S: 467.2342; Found: 467.2339 amu. 
3-Methy•-2-[•-(2•4•6-trimethy•benzenesu•f•ny•amin•)-hepty•]-cyc••pr•pane-•••-dicarb•xy•ic a id 
diethyi ester (14). Purification by flash column chromatography using hexane-EtOAc (7:1) as eluent gave 14 
(0.20 g, 60%) as an oil; IR (CC[4) 3300, 2920, 1725, 1455, 1405, 1370, 1320, 1210 cml; IH NMR (CDCIs) 8 
0.74 (& J = 6.6 Hz, 0.63H, CHsCH), 0.83 (t, J = 7.0 Hz, 3H, CH3CH2CH2), 0.98 (d, J = 6.6 Hz, 2.37H, 
CH3CH), 1.04-1.28 (m, 14H, 2x OCH2CH3, CH3(CH2)4CH2), 1.32-1.37 (m, 0.42H, CH2CH), 1.53-1.83 (m, 
3.58H, CH2CH, H-2, H-3), 2.28+2.29 (2s, 3H, 4-CH3C6H2), 2.64 (s, 4.6H, 2, 6-(CH3)2C6H2), 2.67 (s, 1.4H, 2, 
6-(CH3)2C6H2), 2.98-3.04 (m, 0.21H, CHNH), 3.61-3.68 (m, 0.79H, CHNH), 4.09-4.24 (m, 4H, 2x OCH2CH3), 
4.49 (d, J - 8.0 Hz, 0.79H, NH), 4.57 (d, J = 9.0 Hz, 0.21H, NH), 6.93 (s, 1.58H, 3, 5-C6H2), 6.97 (s, 0.42H, 3, 
5-C6H2); HRMS (M)+; Calcd for C26H41NO6S: 495.2655; Found: 495.2654 ainu. 
3-Butyl-2-[•-(2•4•6-trimethylbenzenesulf•nylamin•)-heptyl]-cycl•pr•pane-•••-dicarb•xylic acid 
diethyl ester (15). Purification by flash column chromatography using hexane-EtOAc (10:1) as eluent gave 15 
(0.25 g, 69%) as an oil; IR (CC14) 3310, 2920, 1720, 1450, 1370, 1330, 1220, 1160 cmI; IH NMR (CDCI3) 8 
0.81-0.86 (m, 6H, 2x CHsCH2CH2), 1.06-1.30 (m, 20H, CH3(CH2)4CH2, CH3(CH2)3CHCH, 2x OCH2CH3), 
1.48-1.52 (m, 2H, CHg(CH2)4CH2), 1.65-1.72 (m, 2H, H-2, H-3), 2.28+2.29 (2s, 3H, 4-CHsC6H2), 2.64+2.66 
(2s, 6H, 2, 6-(CH3)2C6H2), 2.96 (m, 0.10H, CHN), 3.70-3.75 (m, 0.90H, CHN), 4o12-4.21 (m, 4H, 2x 
OCH2CH3), 4.49 (d, J = 8.0 Hz, 0.90H, NH), 4.58 (d, J = 8.0 Hz, 0.10H, NH), 6.93+6.94 (2s, 2H, 3, 5-C6H2); 
Igc NMR (CDCls) 8 14.0, 20.8, 22.4, 23.0, 23.1, 24.0, 29.2, 31.0, 31.3, 31.6, 35.3, 35.5, 36.7, 50.3, 61.1, 61.6, 
131.9, 136.2, 138.4, 141.8, 167.0, 170.7; HRMS (M)+; Calcd for C29H47NO6S: 537.3124; Found: 537.3125 
ainu. 
Methyl (2S, 3S)-3-methyl-l-(toluene-4-sulfonyl)-aziridin-2-carboxylate. Me hyl (2S, 3S)-3-methyl-1- 
trityl-aziridin-2-carboxylate (3.2 g, 8.9 mmol) which was prepared according to a literature method 24 was 
dissolved in 14 mL of chloroform and methanol (1:1 v/v). To this solution was added 7 mL of trifluoroacetic 
acid under ice cooling. The mixture was stirred for 3h in an ice bath and then concentrated in vacuo.  
12272 I. FUNAKI et al. 
Evaporation with newly added ether was repeated several times to remove trifluoroacetic acid as completely as 
possible. The residue was dissolved in ether again and 3-methyl-aziridine-2-carboxylate trifluoroacetate was 
extracted with water (3x 30 mL). To the aqueous extract was added sodium hydrogencarbonate (3.5 g, 0.042 
mol) and 30 mL of ethyl acetate. Tosyl chloride (1.7 g, 8.9 mmol) was added to the mixture under vigorous 
stirring in an ice bath. After stirring overnight at room temperature, the ethyl acetate layer was separated from 
the aqueous layer which was extracted with another portion of ethyl acetate again. The combined organic layers 
were washed with brine, dried over MgSO4, and concentrated. The crude product hus obtained was purified by 
column chromatography (silica, hexane-EtOAc (3:1)) to give 1.2 g (50%) of methyl l-tosyl- 
aziridinecarboxylate: oil; IR (CC14) 2960, 1750, 1440, 1410, 1340, 1280, 1200, 1160 cml; JH NMR (CDC13) 5 
1.32 (d, J = 5.6 Hz, 3H, CH3CHN), 2.45 (s, 3H, C6H4CH3), 3.10 (dq, J = 5.6, 7.4 Hz, 1H, CH3CHN), 3.39 (d, J 
= 7.4 Hz, 1H, CHCO), 3.74 (s, 3H, OCH3), 7.34 (d, J = 8.1 Hz, 2H, 3, 5-C6H4), 7.85 (d, J = 8.4 Hz, 2H, 2, 6- 
C6H4); 13C NMR (CDC13)6 12.2, 21.7, 40.1, 41.2, 52.6, 128.0, 129.8, 134.4, 145.0, 166.3. 
(2S, 3S)-2-Formyl-3-methyi-l-(toluene-4-sulfonyl)-aziridine. A hexane solution of 
diisobutylaluminum-hydride (1.0M, 5.4 mL, 5.4 mmol) was added to a dichloromethane solution (22 mL) of 
methyl cis-3-methyl-l-(toluene-4-sulfonyl)-aziridine-2-carboxylate (1.2 g, 4.5 mmol) at -78 °C under Ar. After 
completion of the addition, the mixture was stirred for one hour and sodium fluoride (1.9 g) and water (1.3 mL) 
were added. The reaction mixture was then warmed slowly to room temperature and the white solid thus 
formed was collected. The filtrate was concentrated in vacuo and column chromatography (hexane-EtOAc 
(2:1)) of the residual oil afforded cis-2-formyl-3-methyl-l-(toluene-4-sulfonyl)-aziridine (0.88 g, 3.7 mmol) in 
82% yield also as an oil. IR (CC14) 2920, 1730, 1440, 1400, 1340, 1215, 1160 cml; JH NMR (CDCI3) 5 1.39 
(d, J = 5.6 Hz, 3H, CH3CHN), 2.46 (s, 3H, CH3C6I-[4), 3.12-3.27 (m, 2H, H-2, H-3), 7.36 (d, J = 8.0 Hz, 2H, 3, 
5-C6H4), 7.84 (d, J = 8.0 Hz, 2H, 2, 6-C6H4), 9.31 (d, J = 5.4 Hz, 1H, CHO); 13C NMR (CDCI3) 5 12.9, 21.5, 
40.6, 46.4, 127.8, 129.8, 145.1,195.3. 
(2R, 3S)-2-[3-Methyl-l-(toluene-4-sulfonyl)-aziridin-2-ylmethylene]-malonic cid diethyl ester (16). 
Diethyl cis-3-methyl-aziridinylmethylene-malonate was prepared from cis-2-formyl-3-methyl-t-tosyl-aziridine 
according to the standard method. After column chromatography (silica-gel, hexane-EtOAc (5:1)), the aziridine 
16 (1.2 g, 85%) was obtained as an oil. IR (CC14) 2980, 1730, 1440, 1395, 1335, 1240, 1160 cmI; IH NMR 
(CDC13) 6 1.21-1.43 (m, 9H, CH3CHN, 2x OCH2CH3), 2.45 (s, 3H, CH3C6H4), 3.15 (dq, J = 5.9, 7.4 Hz, 1H, 
CH3CHN), 3.70 (dd, J = 7.4, 8.4 Hz, 1H, NCHCH=C), 4.23 (q, J = 7.1 Hz, 2H, OCH2CH3), 4.34 (q, J = 7.1 Hz, 
2H, OCH2CH3), 6.61 (d, J = 8.4 Hz, 1H, CHC=C), 7.34 (d, J = 8.1 Hz, 2H, 3, 5-C6H4), 7.81 (d, J = 8.2 Hz, 2H, 
2, 6-C6H4); 13C NMR (CDC13) 8 13.0, 13.9, 14.0, 21.5, 41.4, 41.7, 61.6, 61.7, 127.7, 129.7, 132.6, 134.7, 
140.6, 144.7, 162.7, 163.7. 
3-Buty•-2-[••(•S)-(t••uene•4-su•f•ny•amin•)-ethy•]-cyc••pr•pane-•••-dicarb•xy•ic acid diethyl ester 
(18). Oil; Column chromatography, with hexane-EtOAc (7:1) as eluent; IR (CC14) 3300, 2920, 1720, 1550, 
1370, 1300, 1250, 1210 cml; IH NMR (CDCI3) 8 0.85 (t, J = 6.4 Hz, 3H, CH2CH2CH3), 1.08 (d, J = 6.4 Hz, 
3H, CH3CHN), 1.10-1.41 (m, 12H, (CH2)3CH3, 2x OCH2CH3), 1.76-1.81 (m, 2H, H-2, H-3), 2.41 (s, 3H, 
C6H4CH3), 3.13-3.18 (m, IH, CHN), 4.07-4.27 (m, 4H, 2x OCH2CH3), 4.83 (d, J = 6.8 Hz, 1H, NH), 7.27 (d, J 
= 8.4 Hz, 2H, 3, 5-C6H4), 7.72 (d, J = 8.4 Hz, 2H, 2, 6-C6H4)); 13C NMR (CDCI3)/5 13.9, 14.0, 14.2, 21.1, 21.5, 
22.3, 27.4, 30.7, 31.5, 38.6, 40.1, 48.9, 61.5, 62.0, 127.0, 129.6, 138.7, 143.1,168.0, 168.2. 
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6-Buty•-4-m•thy•-2-•x•-3-(t••uene-4-su•f•ny•)-3-aza-bi•yc••[3••••]hexane-•-carb•xy•ic a id ethyl 
ester (19). A stirred solution of 17 (0.10 g, 0.23 mmol) in EtOH (7 mL), maintained under argon, was treated 
with a few drops of 1.3 M ethanolic solution of NaOEt, set aside overnight at room temperature, and 
concentrated in vacuo. Flash column chromatography (hexane-EtOAc (7:1)) of the residue gave 19 (0.06 g, 
66%) as an oil; IR (CC14) 2960, 1740, 1720, 1370, 1330, 1255, 1170 cml; IH NMR (CDC13) 6 0.79 (t, J = 7.3 
Hz, 3H, CH2CH2CH3), 1.01-1.30 (m, 9H, (CH2)3CH3, OCH2CH3), 1.63 (d, J = 6.4 Hz, 3H, CH3CHN), 2.02- 
2.07 (m, 1H, CHBu), 2.14 (d, J = 8.4 Hz, 1H, H-5), 2.42 (s, 3H, C6H4CH3), 4.16-4.23 (m, 3H, OCH2CH3, 
CH3CHN), 7.31 (d, J = 8.4 Hz, 2H, 3, 5-C6H4), 7.95 (d, J = 8.4 Hz, 2H, 2, 6-C6H4); 13C NMR (CDC13) ~ 13.8, 
14.1, 21.6, 21.8, 22.1,, 23.0, 30.8, 33.3, 34.2, 52.3, 61.8, 128.7, 129.4, 135.6, 145.2, 165.9, 167.9. 
Reactions with Hetero-Organocuprates, Standard procedure. An etherial or dimethyl sulfide (DMS) 
solution (5 mL) of a lithium alkoxide or lithium amide (obtained by treatment of the corresponding alcohol or 
amine (0.74 mmol) with MeLi (0.46 mL; 0.74 mmol) at 0 °C) was added to a stirred, cooled (-50 °C) 
suspension (or solution) of CuI (0.14 g, 0.74 mmol) in ether or DMS (5 mL). The mixture was allowed to warm 
to -30 °C and maintained at this temperature for 30 min, whereon it was cooled to -78 °C and treated with the 
appropriate Grignard reagent (1.0 M in ether, 1.4 mmol) followed immediately by addition of a solution of the 
aziridine 3a (0.30 g, 0.67 mmol) in ether (or DMS; 5 mL). After a further period of 15 min at -78 °C, the 
mixture was allowed to attain room temperature over 3h. With alkoxide hetero-cuprates, the reaction mixture 
was treated with saturated aqueous NHnCI solution (50 mL), whereas with amide hetero-cuprates, the reaction 
was quenched by addition of 5% aqueous H2SO4 (50 mL). The resultant mixtures were treated with ether (50 
mL), filtered through "hyflo", the inorganic material washed with ether, and the combined ether layers washed 
(3x 100 mL) with a saturated aqueous NHnC1 solution - 25% aqueous ammonia mixture (3:1), brine, dried 
(MgSO4) and concentrated in vacuo. Flash column chromatography ( exane-EtOAc (7:1)) of the residue gave 
cyclopropane 5a. 
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